This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Explore ways to get paid quickly online. These solutions can help you receive your earnings without delay.
18,564 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
When headlines shout that Bitcoin is dead, smart investors reset the math. Here’s a practical plan to invest $500 tod...
Tim Cook used the China Development Forum to stress collaboration with Chinese partners as Beijing intensifies policy...
Grief arrives for anyone, but when the world watches, money and plans can unravel faster than a headline. This piece ...
When margins rebound in the energy sector, even senior executives may trim holdings to align with evolving risk and o...
Star Group's Q2 2026 results shed light on the company's path to profitability and growth. This article breaks down t...
Chevron has kept its promise to shareholders with steady cash returns. Discover how 16 quarters of returns totaling o...
In May 2026, two fresh tech IPOS are catching the eye of diligent investors. This guide breaks down why they stand ou...
Ford launches Ford Energy, a battery storage subsidiary, sparking a rally in Ford stock as analysts highlight profita...
The Dow crosses the 50,000 threshold for the first time, rising over 1,200 points in a single session. Analysts call ...
Ares Capital has long dazzled income investors with a high dividend yield. After a challenging quarter, the question ...
California's mom-and-pop shops face shrinking profits as energy, labor, and regulatory costs rise, prompting tougher ...